2020 Global Chlamydia Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chlamydia tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

List of Tables

Major Companies Developing or Marketing Chlamydia Tests

France
Chlamydia Test Volume and Diagnostics Sales Forecast
By Market Segment

France
Chlamydia Diagnostics Sales by Major Supplier

Germany
Chlamydia Test Volume and Diagnostics Sales Forecast
By Market Segment

Germany
Chlamydia Diagnostics Sales by Major Supplier

Italy
Chlamydia Test Volume and Diagnostics Sales Forecast
By Market Segment

Italy
Chlamydia Diagnostics Sales by Major Supplier

Japan
Chlamydia Test Volume and Diagnostics Sales Forecast
By Market Segment

Japan
Chlamydia Diagnostics Sales by Major Supplier

Spain
Chlamydia Test Volume and Diagnostics Sales Forecast
By Market Segment

Spain
Chlamydia Diagnostics Sales by Major Supplier

U.K.
Chlamydia Test Volume and Diagnostics Sales Forecast
By Market Segment

U.K.
Chlamydia Diagnostics Sales by Major Supplier

U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast
By Market Segment

U.S.A.
Chlamydia Diagnostics Sales by Major Supplier


I. Introduction
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako

2020 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study  contains 430 pages, and is designed to help current

USD 3500 View Report

2020 UK Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study  contains 408 pages, and is designed to help current

USD 3500 View Report

2020 Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: US, Europe, Japan--Supplier Shares and Segment Forecasts by Country, Emerging Technologies, Competitive Strategies

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.This new seven-country study contains 570 pages, 42 tables, and is

USD 6500 View Report

2020 Global Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers, Strategic Profiles of Leading Competitors and Emerging Market Entrants

This unique report provides sales and market share estimates for major suppliers of molecular diagnostic products by country.The report also presents strategic assessments of major suppliers and emerging market entrants,

USD 4500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available